Singular Genomics | PREM14A:併購處分代理聲明
Singular Genomics | SCHEDULE 13D/A:其他
Singular Genomics | DEFA14A:其他
Singular Genomics | 8-K:重大事件
Singular Genomics | 4:持股變動聲明-高管 Spaventa Andrew
Singular Genomics | 4:持股變動聲明-高管 Meeter Dalen
Singular Genomics | 4:持股變動聲明-高管 Glezer Eli N.
Singular Genomics | SC 13D/A:超過5%持股股東披露文件(修正)-CRCM Institutional Master Fund (BVI), Ltd.(4.61%),CRCM LP(4.61%)等
Singular Genomics | 4:持股變動聲明-高管 Spaventa Andrew
Singular Genomics | 4:持股變動聲明-高管 Ghai Jyotsna
Singular Genomics | 4:持股變動聲明-高管 Glezer Eli N.
Singular Genomics | 4:持股變動聲明-高管 Meeter Dalen
Singular Genomics | 10-Q:2024財年三季報
Singular Genomics | 8-K:Singular Genomics報告最新更新和2024年第三季度財務業績
Singular Genomics | SC 13D:超過5%持股股東披露文件-CRCM Institutional Master Fund (BVI), Ltd.(5.6%),CRCM LP(5.6%)等
Singular Genomics | 8-K:重大事件
Singular Genomics | SC 13D/A:超過5%持股股東披露文件(修正)-Deerfield Mgmt IV, L.P.(6.66%),Deerfield Private Design Fund IV, L.P.(6.66%)等
Singular Genomics | 4:持股變動聲明-高管 Ghai Jyotsna
Singular Genomics | 8-K:重大事件
Singular Genomics | 4:持股變動聲明-股東 TANG KEVIN